Evelo Biosciences, Inc. (EVLO)
OTCMKTS: EVLO · Delayed Price · USD
0.0001
-0.0504 (-99.80%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Evelo Biosciences Employees
Evelo Biosciences had 66 employees as of December 31, 2022. The number of employees decreased by 56 or -45.90% compared to the previous year.
Employees
66
Change (1Y)
-56
Growth (1Y)
-45.90%
Revenue / Employee
n/a
Profits / Employee
-$1,247,712
Market Cap
1.90K
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
Danaher | 63,000 |
EVLO News
- 9 months ago - Top 5 Health Care Stocks That Are Preparing To Pump In November - Better Therapeutics (NASDAQ:BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT) - Benzinga
- 9 months ago - Top 4 Health Care Stocks That May Rocket Higher This Month - Generation Bio (NASDAQ:GBIO), Evelo Biosciences (NASDAQ:EVLO) - Benzinga
- 9 months ago - Evelo Biosciences to review options after Phase 2 trial of psoriasis treatment fails to meet main goal - Market Watch
- 9 months ago - Evelo Biosciences Announces Top-Line Results From its Phase 2 Clinical Study with EDP2939 in Moderate Psoriasis - GlobeNewsWire
- 1 year ago - Evelo Biosciences Announces Second Quarter Financial Results and Recent Business Highlights - GlobeNewsWire
- 1 year ago - Moderna Co-Founder Bought Up This Embattled Biotech Stock - Barrons
- 1 year ago - Evelo Biosciences Closes $25.5 Million Private Placement - GlobeNewsWire
- 1 year ago - Evelo Biosciences Announces $25.5 Million Private Placement - GlobeNewsWire